Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of sulcardine sulfate tablets for symptomatic premature ventricular contractions with or without non-sustained ventricular tachycardia
CTR20210560Phase 3Active
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulcardine in Premature ventricular complexes (PVC), non-sustained ventricular tachycardia (NSVT), sponsored by Shanghai Institute of Materia Medica. Started Jun 2021; status: active.
02
Drugs
sulcardine
03
Conditions
Premature ventricular complexes (PVC)non-sustained ventricular tachycardia (NSVT)
Beyond the preview
Go deeper on CTR20210560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210560.